2021
Real-world data on usage of scalp cooling for chemotherapy associated alopecia in the United States.
Williams N, Paxman R, Thornhill E, Kassem M, Grimm M, Dulmage B, Cathcart-Rake E, Ruddy K, Pariser A, Gatti-Mays M, Cherian M, VanDeusen J, Stover D, Sardesai S, Wesolowski R, Ramaswamy B, Loprinzi C, Lustberg M. Real-world data on usage of scalp cooling for chemotherapy associated alopecia in the United States. Journal Of Clinical Oncology 2021, 39: e18739-e18739. DOI: 10.1200/jco.2021.39.15_suppl.e18739.Peer-Reviewed Original ResearchScalp coolingNational Comprehensive Cancer NetworkMedical Oncology guidelinesComprehensive Cancer NetworkMajority of patientsOncology guidelinesCategory 2ABreast cancerHair lossCancer NetworkSide effectsChemotherapyLargest reportPatientsReal-world useOlder adultsScalpEuropean SocietyFurther studiesAlopeciaCancerDescriptive statisticsGenitourinaryLungGynecology
2010
Severe and Prolonged Lymphopenia Observed In Patients Treated with Bendamustine and Erlotinib for Metastatic Triple Negative Breast Cancer
Layman R, Ruppert A, Lynn M, Mrozek E, Ramaswamy B, Lustberg M, Susan O, Carothers S, Kraut E, Shapiro C. Severe and Prolonged Lymphopenia Observed In Patients Treated with Bendamustine and Erlotinib for Metastatic Triple Negative Breast Cancer. Blood 2010, 116: 1739. DOI: 10.1182/blood.v116.21.1739.1739.Peer-Reviewed Original ResearchTriple-negative breast cancerPneumocystis carinii pneumoniaDose level 2Metastatic triple-negative breast cancerNational Comprehensive Cancer NetworkDose level 1Serious adverse eventsNegative breast cancerStudy therapyProlonged lymphopeniaOpportunistic infectionsCombination therapyBreast cancerPhase I/II trialAdequate bone marrow functionEpidermal growth factor receptor expressionDepressed CD4 countGrade 3 infectionNon-hematologic toxicitiesOverall hematologic toxicityECOG performance statusGrowth factor receptor expressionWhole brain radiationAbsolute neutrophil countGrowth factor support